MENLO PARK, Calif., Feb. 1, 2024 /PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback